SCHEMBL844918

SCHEMBL844918

Cc1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 2/20 0.56
MPL P40238 2/20 0.48
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 3/20 0.47
HSD17B10 Q99714 3/20 0.47
GLA P06280 2/20 0.47
CYP3A4 P08684 2/20 0.47
LMNA P02545 2/20 0.47
CYP2D6 P10635 2/20 0.47
TP53 P04637 1/20 0.47
POLB P06746 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
DYRK1A Q13627 1/20 0.47
HASPIN Q8TF76 1/20 0.47
DYRK2 Q92630 1/20 0.47
KIF11 P52732 4/20 0.47
CASP1 P29466 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12234734 0.81 PIM3 (0.62) PIM3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL879036 0.80 PIM3 (0.56) PIM3MPLKDM4EALDH1A1HPGD
SCHEMBL845017 0.80 PIM3 (0.79) PIM3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL844551 0.77 KIF11 (0.61) PIM3MPLKDM4EALDH1A1HPGD
SCHEMBL879135 0.77 PIM3 (0.50) PIM3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL22045000 0.75 KIF11 (0.81) PIM3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL9779428 0.75 KIF11 (0.68) PIM3MPLKDM4EALDH1A1HPGD
SCHEMBL5583175 0.74 PIM3 (0.47) PIM3MPLKDM4EALDH1A1HSD17B10
SCHEMBL29518339 0.73 KIF11 (0.78) PIM3MPLKDM4EALDH1A1HPGD
SCHEMBL4256780 0.73 KIF11 (0.78) PIM3MPLKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US claimed
EP-2326649-B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NAT RECH SCIENT (FR) 2012-03-28 EP claimed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US claimed
JP-2011526610-A 2011-10-13 JP claimed
EP-2326649-A1 NOVEL PYRROLO Ý2,3-A¨CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS Centre National de la Recherche Scientifique (FR) 2011-06-01 EP claimed
WO-2010000978-A1 NOVEL PYRROLO [2,3-A] CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-01-07 WO claimed
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US disclosed
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US disclosed
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US disclosed
EP-2326649-B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NAT RECH SCIENT (FR) 2012-03-28 EP disclosed
EP-2326649-B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NAT RECH SCIENT (FR) 2012-03-28 EP disclosed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US disclosed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US disclosed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US disclosed
WO-2010000978-A1 NOVEL PYRROLO [2,3-A] CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors PIM3, PIM1, PIM2 PIM3 1/4885MPL 1739/4885KDM4E 838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.